ELDENT
ActiveSummary
ELDENT has been active since 2004 and the Belgian State Gazette contains no insolvency or warning signals. The 2024 annual accounts show equity of €201,038 and a net result of €24,291. Equity is growing by ~10.1% per year across the filed fiscal years. Its solvency ranks better than 29% of 19923 sector peers (fiscal year 2024). The computed 12-month bankruptcy probability is 0.1% (very low).
Checked score
Score 2024
Axes · tick = 2023
Profitability75▼-3
Solvency68▼-18
Growth78=
Track record100
Bankruptcy probability, 12 months
0.1%
Very low
0%0.5%1.5%4%10%≥ 25%
Credit up to €15,000 at 30 days acceptable
Liquidity ample (current ratio 4.26 against 3.58 in 2023; short-term debt: 8.8% and cash: 1.3% of total assets), but 56.6% of the assets are financed with debt.
Credit check for your own amount and term
Show the recommended maximum : and see how the verdict changes with amount, term and advance.
Signals
Three signals. The signal on the left, the evidence on the right.
−lowers risk○neutral
lowers risk · Lower-failure-rate sector
In this sector companies fail less often than the Belgian average.
Gazette · bankruptcies per sector, NACE 86
Relative position
BE, all sectors
reference
Human health activities (NACE 86)
about 87% fewer bankruptcies
← fewer bankruptcies
more bankruptcies →
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation dateAge against the risk zone
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2024 was due by 31-07-2025 and was filed on 30-06-2025, 31 days ahead of the deadline.
NBB · 10 filingsDeviation from the deadline
2025
not confirmed
2024
31 d early
2023
34 d early
2022
34 d early
2021
32 d early
2020
36 d early
2019
42 d late
← before the deadline
after the deadline →
tick = median of all Belgian filingsring = median in the sector
This company filed its last 6 accounts on average 21 days before the deadline; the sector median for financial year 2024 is 7 days before the deadline, and 36% of the sector filed late.
Checked, nothing found (1)
History
Go further with this company
How much credit can you give this customer, and on what term?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check What other support did companies like this one receive, and it did not?Public money How does this company compare with its sector?Sector benchmark
Is this your company? See how customers and banks see it.
Investigating this company? Keep it with today's facts in a case file.
Financials · fiscal year 2024, micro schema
Equity
€201,038▲ 13.2%
2023 · €177,646
Total assets
€463,379▲ 58.5%
2023 · €292,434
Net result
€24,291▲ 16.7%
2023 · €20,811
Working capital
€132,978▲ 32.0%
2023 · €100,740
Trend over the years
Click a name to add, emphasise or remove a line.Band: the middle half (P25 to P75) of NACE 86, Human health activities, each year against the same schema; no band under 30 filings. Dashed line: the median.
Every figure with its change against the fiscal year before
favourable
unfavourable
Line20202021202220232024
Operating result€11,589▼ 50.5%€5,248▼ 54.7%€60,322▲ 1,049%€37,011▼ 38.6%€43,537▲ 17.6%
Net result€3,197below the sector's middle half▼ 71.5%-€1,481below the sector's middle half€38,577within the sector's middle half€20,811within the sector's middle half▼ 46.1%€24,291within the sector's middle half▲ 16.7%
Equity€123,789within the sector's middle half▲ 1.3%€120,708within the sector's middle half▼ 2.5%€157,685within the sector's middle half▲ 30.6%€177,646within the sector's middle half▲ 12.7%€201,038within the sector's middle half▲ 13.2%
Total assets€312,735within the sector's middle half▲ 0.6%€283,651within the sector's middle half▼ 9.3%€293,761within the sector's middle half▲ 3.6%€292,434within the sector's middle half▼ 0.5%€463,379within the sector's middle half▲ 58.5%
Debt€188,946▲ 0.2%€162,943▼ 13.8%€136,076▼ 16.5%€114,788▼ 15.6%€262,341▲ 129%
Working capital€43,552within the sector's middle half▲ 9.6%€36,576within the sector's middle half▼ 16.0%€73,622within the sector's middle half▲ 101%€100,740within the sector's middle half▲ 36.8%€132,978within the sector's middle half▲ 32.0%
Solvency39.6%within the sector's middle half▲ 0.3pp42.6%within the sector's middle half▲ 3.0pp53.7%within the sector's middle half▲ 11.1pp60.7%within the sector's middle half▲ 7.1pp43.4%within the sector's middle half▼ 17.4pp
Current ratio2.08within the sector's middle half▼ 0.171.92within the sector's middle half▼ 0.163.02within the sector's middle half▲ 1.103.58within the sector's middle half▲ 0.564.26within the sector's middle half▲ 0.68
Return on assets (ROA)1.0%below the sector's middle half▼ 2.6pp-0.5%below the sector's middle half▼ 1.5pp13.1%within the sector's middle half▲ 13.7pp7.1%below the sector's middle half▼ 6.0pp5.2%below the sector's middle half▼ 1.9pp
above
within
below
the middle half (P25 to P75) of NACE 86, Human health activities, each year against the same schema; no band under 30 filings.
Turnover and EBIT margin not published: the micro schema does not require them.
Result per fiscal year
Operating resultNet result
The operating result recovers in 2024; 2024 is 18% above 2023.
Balance-sheet composition
2024 in colour, 2023 as the grey bar beneath
Assets €463,379
Fixed assets
€289,598 ▲ 89.7%
Current assets
€173,780 ▲ 24.3%
Equity and liabilities €463,379
Equity
€201,038 ▲ 13.2%
Debt
€262,341 ▲ 129%
Debt's share of the balance-sheet total rises from 39.3% to 56.6%. Equity and debt are higher.
Key figures and ratios
EBITDA
€68,257▼
2023 · €69,723
Cash flow
€49,012▼
2023 · €53,523
Debt to equity
1.30▲
2023 · 0.65
ROE
12.1%▲
2023 · 11.7%
Interest coverage
6.55▼
2023 · 12.37
Debt ≤ 1 year
€40,802▲
2023 · €39,025
Debt > 1 year
€220,267▲
2023 · €75,463
Income taxes
€11,296▲
2023 · €10,633
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.
Peer companies
Historical observationOf the 20,129 companies that looked in July 2024 the way this one looks now, 0.2% went bankrupt within 24 months and 95% are still going.
- Small
- 20 years or older
- solvency 30% or more
- a profit of 5% of the balance sheet or more
0.2%
went bankrupt
4.7%
stopped otherwise
95%
still going
For this company itself Checked computes a bankruptcy probability of 0.1% over twelve months; the group does not contradict it.
How reliable is this rule?
Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,662 companies of July 2024 its group's bankruptcy share. Expected: 1.5%; actually bankrupt within 24 months: 1.6%.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.4% |
| 3 | 0.5% | 0.5% |
| 4 | 0.6% | 0.7% |
| 5 | 0.8% | 0.9% |
| 6 | 1.2% | 1.3% |
| 7 | 1.5% | 1.7% |
| 8 | 1.7% | 1.7% |
| 9 | 2.7% | 2.8% |
| 10 | 5.3% | 5.7% |
The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 75% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.
An observation about 20,129 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.
Annual accounts
| Line | 2020 | 2021 | 2022 | 2023 | 2024 | Change |
|---|---|---|---|---|---|---|
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets630 | €30,153 | €31,235 | €32,500 | €32,712 | €24,720 | ▼ 24.4% |
| Write-downs on stocks, contracts in progress and trade receivables: additions (reversals)631/4 | - | - | - | €17,233 | €17,233 | = |
| Other operating charges640/8 | - | €1,959 | €1,137 | €1,609 | €20,524 | ▲ 1,175% |
| Gross operating margin9900 | €43,946 | €38,441 | €93,958 | €88,566 | €106,014 | ▲ 19.7% |
| Operating profit (loss)9901 | €11,589 | €5,248 | €60,322 | €37,011 | €43,537 | ▲ 17.6% |
| Financial income75/76B | - | €1,445 | €1,742 | €70 | €2,474 | ▲ 3,419% |
| Recurring financial income75 | €1,101 | €1,445 | €1,742 | €70 | €2,474 | ▲ 3,419% |
| Financial charges65/66B | - | €7,164 | €6,516 | €5,637 | €10,423 | ▲ 84.9% |
| Recurring financial charges65 | €7,667 | €7,164 | €6,516 | €5,637 | €10,423 | ▲ 84.9% |
| Profit (loss) for the period before taxes9903 | €5,023 | -€471 | €55,548 | €31,445 | €35,588 | ▲ 13.2% |
| Income taxes67/77 | €1,825 | €1,010 | €16,971 | €10,633 | €11,296 | ▲ 6.2% |
| Profit (loss) for the period9904 | €3,197 | -€1,481 | €38,577 | €20,811 | €24,291 | ▲ 16.7% |
| Profit (loss) for the period to be appropriated9905 | €3,197 | -€1,481 | €38,577 | €20,811 | €24,291 | ▲ 16.7% |
| Line | 2020 | 2021 | 2022 | 2023 | 2024 | Change |
|---|---|---|---|---|---|---|
| Assets | ||||||
| Total assets20/58 | €312,735 | €283,651 | €293,761 | €292,434 | €463,379 | ▲ 58.5% |
| Fixed assets21/28 | €228,738 | €207,382 | €183,683 | €152,669 | €289,598 | ▲ 89.7% |
| Tangible fixed assets22/27 | €228,738 | €207,382 | €183,683 | €152,669 | €289,598 | ▲ 89.7% |
| Land and buildings22 | - | €185,359 | €170,811 | €148,659 | €280,108 | ▲ 88.4% |
| Plant, machinery and equipment23 | - | - | €1,053 | €2,178 | €8,800 | ▲ 304% |
| Furniture and vehicles24 | - | €22,023 | €11,819 | €1,832 | €690 | ▼ 62.3% |
| Current assets29/58 | €83,997 | €76,268 | €110,077 | €139,765 | €173,780 | ▲ 24.3% |
| Amounts receivable within one year40/41 | €31,942 | €36,999 | €77,193 | €66,305 | €89,868 | ▲ 35.5% |
| Trade receivables40 | - | €6,893 | €12,322 | €12,709 | €2,953 | ▼ 76.8% |
| Other amounts receivable41 | - | €30,106 | €64,871 | €53,596 | €86,915 | ▲ 62.2% |
| Current investments50/53 | €42,700 | €34,192 | €26,192 | €68,733 | €71,390 | ▲ 3.9% |
| Cash at bank and in hand54/58 | €6,919 | €3,221 | €2,297 | €1,791 | €6,056 | ▲ 238% |
| Deferred charges and accrued income490/1 | - | €1,855 | €4,395 | €2,936 | €6,467 | ▲ 120% |
| Equity and liabilities | ||||||
| Total equity and liabilities10/49 | €312,735 | €283,651 | €293,761 | €292,434 | €463,379 | ▲ 58.5% |
| Equity10/15 | €123,789 | €120,708 | €157,685 | €177,646 | €201,038 | ▲ 13.2% |
| Contributions10/11 | - | €18,600 | €18,600 | €18,600 | €18,600 | = |
| Reserves13 | €105,189 | €102,108 | €139,085 | €159,046 | €182,438 | ▲ 14.7% |
| Distributable reserves133 | - | €102,108 | €139,085 | €159,046 | €182,438 | ▲ 14.7% |
| Amounts payable17/49 | €188,946 | €162,943 | €136,076 | €114,788 | €262,341 | ▲ 129% |
| Amounts payable after more than one year17 | €145,801 | €122,950 | €99,320 | €75,463 | €220,267 | ▲ 192% |
| Financial debts170/4 | - | €122,950 | €99,320 | €75,463 | €220,267 | ▲ 192% |
| Amounts payable within one year42/48 | €40,445 | €39,693 | €36,456 | €39,025 | €40,802 | ▲ 4.6% |
| Current portion of amounts payable after more than one year42 | - | €22,851 | €23,630 | €23,857 | €26,586 | ▲ 11.4% |
| Trade debts44 | €2,234 | €1,902 | €586 | €2,549 | €4,717 | ▲ 85.1% |
| Suppliers440/4 | - | €1,902 | €586 | €2,549 | €4,717 | ▲ 85.1% |
| Taxes, remuneration and social security45 | - | €1,800 | €1,800 | €1,833 | €1,800 | ▼ 1.8% |
| Taxes450/3 | - | - | - | €1,833 | - | - |
| Remuneration and social security454/9 | - | €1,800 | €1,800 | - | €1,800 | - |
| Other amounts payable47/48 | - | €13,140 | €10,440 | €10,786 | €7,700 | ▼ 28.6% |
| Accrued charges and deferred income492/3 | - | €300 | €300 | €300 | €1,272 | ▲ 324% |
| Line | 2020 | 2021 | 2022 | 2023 | 2024 | Change |
|---|---|---|---|---|---|---|
| Profit (loss) for the period9904 | €3,197 | -€1,481 | €38,577 | €20,811 | €24,291 | ▲ 16.7% |
| + Depreciation and write-downs630 | €30,153 | €31,235 | €32,500 | €32,712 | €24,720 | ▼ 24.4% |
| Operating cash flow (approximation) | €33,350 | €29,754 | €71,076 | €53,523 | €49,012 | ▼ 8.4% |
| Investment in fixed assets (approximation) | - | -€9,879 | -€8,801 | -€1,698 | -€161,649 | ▼ 9,420% |
| Change in cash | - | -€3,697 | -€924 | -€507 | €4,265 | ▲ 942% |
Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.
Timeline · acts, filings and financial milestones
2025
30-06
NBB filing
Annual accounts filed
fiscal year 2024 · micro schema
2024
31-12
Financial
Equity above €200,000Eq €201,038 ▲13.2%
3 profitable years in a row build equity to €201,038.
27-06
NBB filing
Annual accounts filed
fiscal year 2023 · micro schema
2023
27-06
NBB filing
Annual accounts filed
fiscal year 2022 · micro schema
2022
31-12
Financial
Back to profitnet €38,577
Net result €38,577 after one loss-making year.
31-12
Financial
Equity above €150,000Eq €157,685 ▲30.6%
Equity rises from €120,708 to €157,685.
29-06
NBB filing
Annual accounts filed
fiscal year 2021 · micro schema
2021
31-12
Financial
Weakest financial yearnet -€1,481
Net result drops to -€1,481, the lowest in the series; recovery starts the following year.
25-06
NBB filing
Annual accounts filed
fiscal year 2020 · micro schema
2020
11-09
NBB filing
Annual accounts filed
fiscal year 2019 · micro schema · 42 days late
2019
29-08
NBB filing
Annual accounts filed
fiscal year 2018 · micro schema · 29 days late
2018
27-08
NBB filing
Annual accounts filed
fiscal year 2017 · micro schema · 27 days late
2017
25-07
NBB filing
Annual accounts filed
fiscal year 2016 · micro schema
2016
22-07
NBB filing
Annual accounts filed
fiscal year 2015 · abbreviated schema
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 2 acts read
About the unread acts
We know of 2 Belgian State Gazette acts for this company. None of them has been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.
Directors · office · real estate
Directors
2 acts for this company are in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Gingelom · 1 establishment unit since 2021
Ground area
1,385 m²
Building footprint
351 m²
Volume, LiDAR
2,470 m³
2 parcels, Flanders · tallest building 11.5 m, ±3 floors. Linked by address, not a title deed.
1 establishment unit
ELDENT
since 20212.314.208.281
2 parcels
Flanders
2
(100%)
| Parcel (capakey) | Region | Area | Buildings | Height / fl. |
|---|---|---|---|---|
| 71040A0345/00D002 | Flanders | 892 m² | 1 · 130 m² | 8.7 m · 2 fl. |
| 24059B0182/00G000indicative | Flanders | 493 m² | 1 · 221 m² | 11.5 m · 3 fl. |
Linked by address, not proof of ownership
Good to know
1 of 2 parcels with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.
Public money · subsidies and aid
Flemish government
2025 · 1 entry · 2,420 EUR awarded · 2,420 EUR paid| Year | Entries | awarded | paid |
|---|---|---|---|
| 2025 | 1 | 2,420 EUR | 2,420 EUR |
Similar companies · same sector, comparable size
DENT A VIE
BE 0766.941.386
Sprimont · Eq €201,166
H&Z DENTAL
BE 1006.998.174
Schaarbeek · Eq €201,198
Dentico
BE 1000.022.290
Gent · Eq €200,874
ASTRID VANHOUTTE
BE 0501.822.669
Mechelen · Eq €200,733
JORDENT SRL
BE 0771.514.541
Orp-Jauche · Eq €201,408
Of 6,945 companies in sector 86230 we hold annual accounts for 4,296. 3,797 are within a factor 10 of this equity. The 5 above are the closest to it. See the whole sector
Identification & contact
Identification
Legal formPrivate limited company
Founded10-12-2004
Fiscal year end31-12
Activities, NACEBEL 2025
86230Dental practice
E-invoicing
Reachable via Peppol
Peppol ID
0208:0870501556
Also
9925:BE0870501556
Registered
13-03-2026
Register as of 28 September 2026 · Peppol Directory
Scores and ratios are computed by Checked and are not a credit decision.